Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Jan 30;16(1):804-806.
doi: 10.21037/jtd-23-1633. Epub 2024 Jan 15.

Therapeutic strategy for lung adenocarcinoma with pure ground-glass opacity: surgery, radiotherapy, or watchful waiting?

Masanori Shimomura  1 , Masayoshi Inoue  1
Affiliations
Editorial

Therapeutic strategy for lung adenocarcinoma with pure ground-glass opacity: surgery, radiotherapy, or watchful waiting?

Masanori Shimomura et al. J Thorac Dis. .
No abstract available

Keywords: Early-stage lung cancer; ground-glass opacity (GGO); sublobar resection.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: Both authors have completed the ICMJE uniform disclosure form (available at https://jtd.amegroups.com/article/view/10.21037/jtd-23-1633/coif). The authors have no conflicts of interest to declare.

Comment on

References

    1. Cardillo G, Petersen RH, Ricciardi S, et al. European guidelines for the surgical management of pure ground-glass opacities and part-solid nodules: Task Force of the European Association of Cardio-Thoracic Surgery and the European Society of Thoracic Surgeons. Eur J Cardiothorac Surg 2023;64:ezad222. 10.1093/ejcts/ezad222 - DOI - PubMed
    1. Obayashi K, Shimizu K, Nakazawa S, et al. The impact of histology and ground-glass opacity component on volume doubling time in primary lung cancer. J Thorac Dis 2018;10:5428-34. 10.21037/jtd.2018.08.118 - DOI - PMC - PubMed
    1. Mikami N, Takeda A, Hashimoto A, et al. CT Findings and Treatment Outcomes of Ground-Glass Opacity Predominant Lung Cancer After Stereotactic Body Radiotherapy. Clin Lung Cancer 2022;23:428-37. 10.1016/j.cllc.2022.03.007 - DOI - PubMed
    1. Jang JY, Kim SS, Song SY, et al. Clinical Outcome of Stereotactic Body Radiotherapy in Patients with Early-Stage Lung Cancer with Ground-Glass Opacity Predominant Lesions: A Single Institution Experience. Cancer Res Treat 2023;55:1181-9. 10.4143/crt.2022.1656 - DOI - PMC - PubMed
    1. Saji H, Okada M, Tsuboi M, et al. Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial. Lancet 2022;399:1607-17. 10.1016/S0140-6736(21)02333-3 - DOI - PubMed